[Translated article] Adjusted indirect comparison of zanubrutinib and ibrutinib in first-line treatment of chronic lymphocytic leukemia Salmeron-Navas; Barreiro-Fernandez; Fenix-Caballero;

Comparación indirecta ajustada de zanubrutinib e ibrutinib en el tratamiento de primera línea de la leucemia linfocítica crónica Salmeron-Navas; Barreiro-Fernandez; Fenix-Caballero;

Cost-minimisation analysis of chronic lymphocytic leukemia in Spain in the era of oral targeted therapies Belén Montañés; Gema Casado; Ángeles Medina; Pablo Nieto; Ángel Ramírez-Payer;